多重乙-辅酶甲脱酶缺乏与塞特拉林使用有关 - 有一种获得的形式吗?
Sofie Sunebo1, Hanna Appelqvist1, Bo Häggqvist1
1Department of Neurology in Linköping, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Annals of neurology
|August 2, 2024
概括
塞特拉林可能会导致多重乙辅酶A脱酶缺乏症 (MADD) 的获得形式. riboflavin 治疗改善了所有患者的症状和生物标志物,这表明它对遗传和获得的 MADD 都有效.
科学领域:
- 生物化学 生物化学
- 神经学 神经学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 多重乙辅酶甲脱酶缺乏症 (MADD) 是一种脂肪酸氧化障碍和代谢的先天性错误.
- 越来越多的MADD患者缺乏可识别的致病突变.
研究的目的:
- 调查MADD的潜在非遗传原因.
- 为了确定患有无法解释的遗传发现的患者中MADD的原因.
主要方法:
- 审查了9名晚期发病的MADD患者的记录,诊断在10年内.
- 分析症状,临床发现,并发病,药物和诊断调查.
- 进行了补充肌肉组织调查,并审查了治疗反应.
主要成果:
- 在9名患者中,只有2名患有MADD的可能遗传原因.
- 所有没有遗传突变的7名患者都接受了塞特拉林治疗,这与症状恶化相关.
- discontinuation of sertraline改善了阿西尔卡尼丁的概况;所有患者都对利博弗拉治疗做出了反应.
结论:
- 塞特拉林可能会诱导一种获得的MADD形式.
- 利博弗拉治疗对获得的MADD有效,类似于遗传形式.
- 建议在获得MADD的患者中停止使用塞特拉林.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
110
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
110
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
236
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
236
Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
Structure-Activity Relationships and Drug Design
689
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
689
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K


